Charles Schwab Investment Management Inc Vericel Corp Call Options Transaction History
Charles Schwab Investment Management Inc
- $515 Billion
- Q3 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding VCEL
# of Institutions
274Shares Held
48.9MCall Options Held
91.1KPut Options Held
39.8K-
Black Rock Inc. New York, NY8.06MShares$457 Million0.01% of portfolio
-
Brown Capital Management LLC Baltimore, MD3.83MShares$217 Million3.54% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.44MShares$196 Million0.0% of portfolio
-
State Street Corp Boston, MA2.48MShares$141 Million0.01% of portfolio
-
Invesco Ltd. Atlanta, GA2.37MShares$134 Million0.02% of portfolio
About Vericel Corp
- Ticker VCEL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 47,178,000
- Market Cap $2.68B
- Description
- Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...